x min read

Hot Stocks in Action: Regency Energy Partners LP (NYSE:RGP), Bristol-Myers Squibb Company (NYSE:BMY), Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR)

Hot Stocks in Action: Regency Energy Partners LP (NYSE:RGP), Bristol-Myers Squibb Company (NYSE:BMY), Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR)
Written by
Ryan Mitchell
Published on
November 18, 2014
Copy URL
Share on LinkedIn
Share on Reddit
Share on Twitter/X
Share on Facebook
InsidrFinancial

Energy Transfer Partners, L.P. (ETP) and Regency Energy Partners LP (NYSE:RGP) Trend Analysis announced that their joint venture, Lone Star NGL LLC, has Board of Directors authorization to construct a 533 mile, 24 and 30-inch natural gas liquids (NGL) pipeline from the Permian Basin to Mont Belvieu, Texas, and convert Lone Star's existing West Texas 12-inch NGL pipeline into crude oil/condensate service. On the other consideration, Regency Energy Partners LP (NYSE:RGP) begun last trade with a price of $29.15 and throughout the trading session climbed at $29.68. The day-trade ended with a gain of 0.75% to closed at $29.66. The stock is going forward its fifty-two week low with 33.14% and lagging behind from its 52 week high price with -10.10%. RGP last month stock price volatility remained 2.53%.Bristol-Myers Squibb Company (NYSE:BMY) Trend Analysis released that results from the first part of the Phase 3 ANNEXA studies. Andexanet alfa produced rapid and nearly complete reversal (by approximately 94 percent, p value. This first part of the Phase 3 ANNEXA-A examination achieved all of its primary and secondary endpoints with statistical significance. Shares of Bristol-Myers Squibb Company (NYSE:BMY) opened at $57.73 with 1658.78 million outstanding shares and hit to its highest price of $58.57 during the day and finally closed at $58.43 by scoring 0.83%. In the whole session, it traded on volume of 4.69 Million shares, which turned higher than its average volume.Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) Trend Analysis released that a licensing and collaboration contract with Dicerna (DRNA). TKMR has licensed its proprietary lipid nanoparticle delivery technology for exclusive use in DRNA's primary hyperoxaluria type 1 (PH1) development program. Tekmira Pharmaceuticals Corp. (NASDAQ:TKMR) stock hit highest price at $17.44, beginning with a price of $17.00 to the closed at 17.24 by an increase of 5.06% with a day range of $16.71-$17.44. The total volume of 867233 shares held in the session was surprisingly higher than its average volume of 4121.88 shares.

Discover Hidden Gems

Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.

Recommended for You